Technology

A very modern challenge: The Human Immunome Project

A very modern challenge: The Human Immunome Project

“Pioneering a new era of human health”, scientists at the Human Immune Project are tackling “one of the greatest remaining frontiers”: the human immune system. Formerly known as the Human Vaccines Project, and modelled after the Human Genome Project, they are...

GSK Shingrix vaccine success drives ¾ revenues

GSK Shingrix vaccine success drives ¾ revenues

A November press release from GSK indicates a rise in revenue and profit, attributed to its Shingrix vaccine for shingles. Pharmaphorum suggests that, since the “spin-off” from Haleon in July it has “exceeded analysts’ estimates”.   Positive quarter  GSK recorded an...

Vaxxinity platform aims to conquer chronic diseases

Vaxxinity platform aims to conquer chronic diseases

Migraines affect an estimated 10% of people worldwide, causing severe headaches and other symptoms such as light sensitivity, nausea, and vomiting. The WHO reports that migraines are “more common in women, usually by a factor of about 2:1”. This is attributed to...

Sanofi deploys Dassault’s virtual twin experiences

Sanofi deploys Dassault’s virtual twin experiences

In October 2022 Sanofi and Dassault Systemes announced a partnership to optimise Sanofi’s “EVolutive Facilities” (EVF). These are “state-of-the-art" manufacturing sites powered by “big data and digital”, and Sanofi describes them as the “future of vaccine...

On Polio Day PharmaJet announces USAID grant

On Polio Day PharmaJet announces USAID grant

The 24th of October 2022 was World Polio Day, which draws attention to the continued global fight against polio. This year, PharmaJet, the developer of a needle-free delivery platform, announced that it had received a multi-year grant from the United States Agency for...

WHO and IDIA renew agreement for health impact

WHO and IDIA renew agreement for health impact

In October 2022 the WHO announced the renewal of a strategic Collaboration Agreement with the International Innovation Alliance (IDIA) to “support the scaling of health innovations to the end of 2023”. The WHO outlined a shared goal: “to jointly accelerate health...

Airfinity predicts jab price increase to meet demand

Airfinity predicts jab price increase to meet demand

In October 2022 the health analytics specialist Airfinity predicted that the COVID-19 vaccine market will generate $60 billion for this year, despite a drop in sales. Airfinity suggests that this will come at a cost for buyers, who will face an increase in price per...